Intravenous Immunoglobulin Therapy is Effective and Acts Independently of the Neonatal Fc-receptor in Experimental Epidermolysis Bullosa Acquisita

被引：0

作者：

Kasperkiewicz, M. ^{[1
]}

Ishii, N. ^{[1
]}

Hirose, M. ^{[1
]}

Freitag, M. ^{[1
]}

Schmidt, E. ^{[1
]}

Recke, A. ^{[1
]}

Zillikens, D. ^{[1
]}

Ludwig, R. J. ^{[1
]}

机构：

[1] Univ Lubeck, Lubeck, Germany

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2009年 / 129卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：S95 / S95

页数：1

共 35 条

[21] Fc-receptor antagonists are effective in the therapy of autoimmune disease animal models
Jacob, U.
Pellkofer, H. L.
Schaefer, B.
Breithaupt, C.
JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 166 - 166
[22] C5aR2 Deficiency Ameliorates Inflammation in Murine Epidermolysis Bullosa Acquisita by Regulating Fc? Receptor Expression on Neutrophils
Seiler, Daniel Leonard
Kleingarn, Marie
Kahler, Katja Hendrika
Gruner, Caroline
Schanzenbacher, Jovan
Ehlers-Jeske, Elvira
Kenno, Samyr
Sadik, Christian David
Schmidt, Enno
Bieber, Katja
Kohl, Jorg
Ludwig, Ralf J.
Karsten, Christian Marcel
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (10) : 2715 - +
[23] Neonatal Fc receptor induces intravenous immunoglobulin growth suppression in Langerhans cell histiocytosis
Nabeshima, Yuka
Kataoka, Tatsuki R.
Ueshima, Chiyuki
Saito, Narumi
Hirata, Masahiro
Takeuchi, Yasuhide
Takei, Yusuke
Moriyoshi, Koki
Ono, Kazuo
Haga, Hironori
PATHOLOGY INTERNATIONAL, 2021, 71 (03) : 191 - 198
[24] Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: clinical outcome and post-treatment long-term follow-up
Ahmed, A. R.
Guercan, H. M.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (09) : 1074 - 1083
[25] The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita
Sadeghi, Hengameh
Gupta, Yask
Moeller, Steffen
Samavedam, Unni K.
Behnen, Martina
Kasprick, Anika
Bieber, Katja
Mueller, Susen
Kalies, Kathrin
Marques, Andreia de Castro
Recke, Andreas
Schmidt, Enno
Zillikens, Detlef
Laskay, Tamas
Mariani, Jean
Ibrahim, Saleh M.
Ludwig, Ralf J.
JOURNAL OF PATHOLOGY, 2015, 237 (01): : 111 - 122
[26] The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita
Sadeghi, H.
Gupta, Y.
Moeller, S.
Samavedam, U. K.
Behnen, M.
Mueller, S.
Kalies, K.
Marques, A. de Castro
Recke, A.
Schmidt, E.
Zillikens, D.
Laskay, T.
Mariani, J.
Ibrahim, S.
Ludwig, R. J.
EXPERIMENTAL DERMATOLOGY, 2015, 24 (03) : E24 - E24
[27] IgG Fc receptor polymorphisms in human disease: Implications for intravenous immunoglobulin therapy
Binstadt, BA
Geha, RS
Bonilla, FA
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (04) : 697 - 703
[28] RETICULOENDOTHELIAL SYSTEM FC-RECEPTOR FUNCTION IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA AFTER TREATMENT WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN
BUDDE, U
AUCH, D
NIESE, D
SCHAFER, G
RESKE, SN
SCHMIDT, RE
SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1986, 37 (02): : 125 - 129
[29] Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita
Zillikens, Hannah
Kasprick, Anika
Osterloh, Colin
Gross, Natalie
Radziewitz, Michael
Hass, Cindy
Hartmann, Veronika
Behnen-Harer, Martina
Ernst, Nancy
Boch, Katharina
Vidarsson, Gestur
Visser, Remco
Laskay, Tamas
Yu, Xinhua
Petersen, Frank
Ludwig, Ralf J.
Bieber, Katja
FRONTIERS IN MEDICINE, 2021, 8
[30] ENHANCED FC-RECEPTOR EXPRESSION BY A SUBPOPULATION OF MURINE INTRA-TUMOR MACROPHAGES FOLLOWING INTRAVENOUS CORYNEBACTERIUM-PARVUM THERAPY
MOORE, K
MCBRIDE, WH
BRITISH JOURNAL OF CANCER, 1983, 47 (06) : 797 - 802

← 1 2 3 4 →